Avinza Elan.Curr Opin Investig Drugs 2002 Sep; 3(9):1369-72.CO
Abstract
Avinza is a once-daily morphine sulfate controlled-release formulation utilizing SODAS (Spheroidal Oral Drug Absorption System) technology developed by Elan and Ligand for the potential treatment of pain [220806], [223862]. This multiparticulate product is designed to provide a rapid onset of action together with a sustained therapeutic effect over 24 h. It is thought that once-daily administration should improve compliance and help eliminate breakthrough pain which is a feature of many twice-daily products, thereby providing better pain management [220806].
Pub Type(s)
Journal Article
Review
Language
eng
PubMed ID
12498014
Citation
Semenchuk, Marilyn R.. "Avinza Elan." Current Opinion in Investigational Drugs (London, England : 2000), vol. 3, no. 9, 2002, pp. 1369-72.
Semenchuk MR. Avinza Elan. Curr Opin Investig Drugs. 2002;3(9):1369-72.
Semenchuk, M. R. (2002). Avinza Elan. Current Opinion in Investigational Drugs (London, England : 2000), 3(9), 1369-72.
Semenchuk MR. Avinza Elan. Curr Opin Investig Drugs. 2002;3(9):1369-72. PubMed PMID: 12498014.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Avinza Elan.
A1 - Semenchuk,Marilyn R,
PY - 2002/12/25/pubmed
PY - 2003/5/28/medline
PY - 2002/12/25/entrez
SP - 1369
EP - 72
JF - Current opinion in investigational drugs (London, England : 2000)
JO - Curr Opin Investig Drugs
VL - 3
IS - 9
N2 - Avinza is a once-daily morphine sulfate controlled-release formulation utilizing SODAS (Spheroidal Oral Drug Absorption System) technology developed by Elan and Ligand for the potential treatment of pain [220806], [223862]. This multiparticulate product is designed to provide a rapid onset of action together with a sustained therapeutic effect over 24 h. It is thought that once-daily administration should improve compliance and help eliminate breakthrough pain which is a feature of many twice-daily products, thereby providing better pain management [220806].
SN - 1472-4472
UR - https://www.unboundmedicine.com/prime/citation/12498014/Avinza_Elan.
DB - PRIME
DP - Unbound Medicine
ER -
